SciELO - Scientific Electronic Library Online

 
vol.1 issue4The School of Medicine and Surgery of Pará, Brazil: from establishment to federalization, 1919-1950Prevalence of intestinal parasites in children from riverine communities in the Municipality of Coari, on the Middle Solimões River, Amazonas, Brazil author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Pan-Amazônica de Saúde

Print version ISSN 2176-6215On-line version ISSN 2176-6223

Abstract

PEREIRA, Felicidade Mota; BERTOLLO, Leonardo Assis  and  ZARIFE, Maria Alice Sant'Anna. Comparison of two automated chemiluminescence tests for the detection of antibodies against the hepatitis C virus. Rev Pan-Amaz Saude [online]. 2010, vol.1, n.4, pp.17-21. ISSN 2176-6215.  http://dx.doi.org/10.5123/S2176-62232010000400003.

INTRODUCTION: A correct diagnosis of hepatitis C virus (HCV) infection is important because treatment is highly expensive and has severe side effects. The assays for the detection of antibodies against HCV (anti-HCV) have undergone several changes, and third-generation tests have been widely used due to their increased sensitivity and specificity. OBJECTIVE: In this study, we aimed to compare two commercially available, automated third-generation chemiluminescence tests for the detection of anti-HCV antibodies. METHODS: We analyzed 67 samples from the serum databank from the Laboratório Central de Saúde Pública do Estado da Bahia (LACEN-BA). The reagents examined were the automated ARCHITECT® anti-HCV assay (Abbott Diagnostics, Wiesbaden, Germany) and Elecsys® anti-HCV assay (Roche Diagnostics, Basel, Switzerland) tests and the confirmatory Recombinant Immunoblot Assay (RIBA) test (Chiron RIBA VHC 3.0 SIA, Chiron Corporation, Emeryville, CA, USA). RESULTS: The Architect anti-HCV assay indicated 18 positive samples, whereas 39 were negative and ten were indeterminate. The Elecsys anti-HCV assay indicated 47 negative and 20 positive samples and no indeterminate samples. Of the ten indeterminate samples indicated by the Architect anti-HCV assay, five were negative by the RIBA test and five were indeterminate. All indeterminate samples indicated by the RIBA test were reactive against the c33 protein. CONCLUSION: The agreement between the two tests (62 samples) was 91.9%. The Elecsys anti-HCV assay appears to be less sensitive than the Architect anti-HCV, particularly for the detection of the c33 protein shown by the RIBA test. In addition, the Architect anti-HCV assay indicated more indeterminate results out of the negative samples confirmed by the RIBA test, which suggests a lower specificity than the Elecsys anti-HCV assay.

Keywords : Hepatitis C; Hepatitis C Antibodies; Laboratory Test.

        · abstract in Portuguese | Spanish     · text in English | Portuguese | Spanish     · English ( pdf ) | Spanish ( pdf ) | Portuguese ( pdf )